Landfar Bio-medicine Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Public

  • Employees
  • 1,542

Employees

  • Stock Symbol
  • 600396

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $1.44
  • (As of Friday Closing)

Landfar Bio-medicine General Information

Description

Huadian Liaoning Energy Development Co Ltd is engaged in Thermal power generation; heating, and heat supply.

Contact Information

Website
www.600396.com
Formerly Known As
NanHua Bio-medicine Company
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 23-26, Tower B
  • Taichen Business Mansion
  • Shenyang, Liaoning 110006
  • China
+86
Primary Industry
Energy Production
Other Industries
Energy Infrastructure
Stock Exchange
SHG
Vertical(s)
Corporate Office
  • 23-26, Tower B
  • Taichen Business Mansion
  • Shenyang, Liaoning 110006
  • China
+86

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Landfar Bio-medicine Stock Performance

As of 13-Nov-2026, Landfar Bio-medicine’s stock price is $1.44. Its current market cap is $2.12B with 1.47B shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.44 $1.48 $0.40 - $3.40 $2.12B 1.47B 108M

Landfar Bio-medicine Financials Summary

As of 30-Sep-2026, Landfar Bio-medicine has a trailing 12-month revenue of $637M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 4,459,170 2,071,466 1,972,787 1,980,034
Revenue 636,940 605,159 620,746 886,930
EBITDA 54,105 159,882 148,268 508,113
Net Income (10,636) 3,955 11,808 302,525
Total Assets 2,618,520 2,158,794 1,931,548 1,957,841
Total Debt 1,685,955 1,170,215 1,036,650 1,439,922
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Landfar Bio-medicine Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Landfar Bio-medicine Investments & Acquisitions (2)

Landfar Bio-medicine’s most recent deal was a Corporate Asset Purchase with Shenyang Hepingwan Urban Development (Usage Rights of a Building in Shenyang, China) for . The deal was made on 03-Nov-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Shenyang Hepingwan Urban Development (Usage Rights of a Building in Shenyang, China) 03-Nov-2026 Corporate Asset Purchase Buildings and Property
Liaoning Huadian Tieling Power Company 10-Dec-2014 Merger/Acquisition Energy Transportation
To view Landfar Bio-medicine’s complete investments and acquisitions history, request access »

Landfar Bio-medicine ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Utilities

Industry

Rank

Percentile

Electric Utilities

Subindustry

Rank

Percentile

To view Landfar Bio-medicine’s complete esg history, request access »

Landfar Bio-medicine FAQs

  • When was Landfar Bio-medicine founded?

    Landfar Bio-medicine was founded in 1998.

  • Where is Landfar Bio-medicine headquartered?

    Landfar Bio-medicine is headquartered in Shenyang, China.

  • What is the size of Landfar Bio-medicine?

    Landfar Bio-medicine has 1,542 total employees.

  • What industry is Landfar Bio-medicine in?

    Landfar Bio-medicine’s primary industry is Energy Production.

  • Is Landfar Bio-medicine a private or public company?

    Landfar Bio-medicine is a Public company.

  • What is Landfar Bio-medicine’s stock symbol?

    The ticker symbol for Landfar Bio-medicine is 600396.

  • What is the current stock price of Landfar Bio-medicine?

    As of 13-Nov-2026 the stock price of Landfar Bio-medicine is $1.44.

  • What is the current market cap of Landfar Bio-medicine?

    The current market capitalization of Landfar Bio-medicine is $2.12B.

  • What is Landfar Bio-medicine’s current revenue?

    The trailing twelve month revenue for Landfar Bio-medicine is $637M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process